Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib March 10, 2018 admin CEO Interview, Healthcare Comments Off on Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd. Your privacy is our priority. Your email address will never be sold or shared with anyone else.